Pharma Deals Review, Vol 2007, No 83 (2007)

Font Size:  Small  Medium  Large

Schering-Plough and Merck & Co. to Develop new Cholesterol Treatment

Business Review Editor

Abstract


Schering-Plough and Merck & Co. entered into agreement to develop fixed-dose ezetimibe (Zetia®) and atorvastatin (Lipitor®) combination product for lowering cholesterol.

Full Text: pdf

Add comment

Creative Commons License
This work is licensed under a Creative Commons Attribution 3.0 License.